Carisma Therapeutics Inc. - CARM
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck & Co., Inc. | History | No change | 1,473,240 | 47 | 0.01% | 0.02% | 1 | 0 | 0.0% | Q1 2026 | May 13, 2026 |
| XTX Topco Ltd | History | Closed out | 0 | 0 | — | 0.0% | — | -40,097 | -100.0% | Q1 2026 | May 15, 2026 |
| Empowered Funds, LLC | History | Closed out | 0 | 0 | — | 0.0% | — | -30,988 | -100.0% | Q1 2026 | May 14, 2026 |
| Baader Bank Aktiengesellschaft | History | Closed out | 0 | 0 | — | — | — | -19,515 | -100.0% | Q1 2026 | May 08, 2026 |
| IFP Advisors, Inc | History | Closed out | 0 | 0 | — | — | — | -206 | -100.0% | Q1 2026 | Apr 13, 2026 |
| Ascentis Independent Advisors | History | New | 200 | 0 | — | — | — | +200 | New | Q1 2026 | Apr 28, 2026 |
| Union Bancaire Privee, UBP SA | History | No change | 785 | 0 | — | — | — | 0 | 0.0% | Q1 2026 | Apr 22, 2026 |
| ORG Partners LLC | History | No change | 200 | 0 | — | — | — | 0 | 0.0% | Q4 2025 | Jan 14, 2026 |